Sanford, Mark. Avanafil: A Review of Its Use in Patients with Erectile Dysfunction. „Drugs Aging”. 30 (10), s. 853-862, 2013. DOI: 10.1007/s40266-013-0112-x. PMID: 23955441.
Goldstein, Irwin, McCullough, Andrew R., Jones, LeRoy A., Hellstrom, Wayne J. i inni. A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Avanafil in Subjects with Erectile Dysfunction. „The Journal of Sexual Medicine”. 9 (4), s. 1122-1133, 2012. DOI: 10.1111/j.1743-6109.2011.02629.x. PMID: 22248153.
G. T. Kedia, S. Ückert, F. Assadi-Pour, M. A. Kuczyk, Knut Albrecht. Avanafil for the treatment of erectile dysfunction: initial data and clinical key properties. „Therapeutic Advances in Urology”. 5 (1), s. 35-41, 2013. DOI: 10.1177/1756287212466282. PMID: 23372609. PMCID: PMC3547533.
nih.gov
ncbi.nlm.nih.gov
Sanford, Mark. Avanafil: A Review of Its Use in Patients with Erectile Dysfunction. „Drugs Aging”. 30 (10), s. 853-862, 2013. DOI: 10.1007/s40266-013-0112-x. PMID: 23955441.
Goldstein, Irwin, McCullough, Andrew R., Jones, LeRoy A., Hellstrom, Wayne J. i inni. A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Avanafil in Subjects with Erectile Dysfunction. „The Journal of Sexual Medicine”. 9 (4), s. 1122-1133, 2012. DOI: 10.1111/j.1743-6109.2011.02629.x. PMID: 22248153.
G. T. Kedia, S. Ückert, F. Assadi-Pour, M. A. Kuczyk, Knut Albrecht. Avanafil for the treatment of erectile dysfunction: initial data and clinical key properties. „Therapeutic Advances in Urology”. 5 (1), s. 35-41, 2013. DOI: 10.1177/1756287212466282. PMID: 23372609. PMCID: PMC3547533.